Efficacy and Safety of Patupilone in Patients With Advanced Solid Tumors in Japan

Inclusion criteria: * Patients with a histologically/cytologically confirmed diagnosis of advanced solid tumors refractory to or unsuitable for standard therapy, or for whom no standard therapy exists * Patients with WHO Performance Status of 0-1 ( Karnofsky Performance Status of 80-100) * At least one measurable lesion Exclusion criteria: * Patients with any peripheral neuropathy * Patients with unresolved diarrhea * Patients with severe and/or uncontrolled medical conditions or infections that require systemic therapy Other protocol-defined inclusion/exclusion criteria may apply